Genzyme
Executive Summary
Bulk clindamycin phosphate will be first product manufactured at firm's new manufacturing facility in Haverhill, U.K. Firm expects the new operations to generate sales in excess of $ 11 mil. in 1988, with 85% of the revenue from exports. Construction of the facility was supported by almost $ 700,000 in grant support from the U.K. Department of Trade and Industry.